Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 EUR | -0.98% | -2.30% | +30.51% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | AIB buys back EUR999 million worth of shares from Irish government | AN |
Sales 2024 * | 4.56B 4.95B | Sales 2025 * | 4.34B 4.72B | Capitalization | 12.22B 13.29B |
---|---|---|---|---|---|
Net income 2024 * | 1.76B 1.92B | Net income 2025 * | 1.56B 1.7B | EV / Sales 2024 * | 2.68 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
7.04
x | P/E ratio 2025 * |
7.33
x | Employees | - |
Yield 2024 * |
5.95% | Yield 2025 * |
6.31% | Free-Float | 68.01% |
Latest transcript on AIB Group plc
1 week | -2.30% | ||
Current month | -3.14% | ||
1 month | +1.88% | ||
3 months | +14.79% | ||
6 months | +16.48% | ||
Current year | +30.51% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 13-08-31 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 21-01-21 |
James Pettigrew
CHM | Chairman | 65 | 21-10-27 |
Brendan McDonagh
BRD | Director/Board Member | 66 | 16-10-26 |
Date | Price | Change |
---|---|---|
24-06-05 | 5.04 | -0.98% |
24-06-04 | 5.09 | -3.14% |
24-06-03 | 5.255 | 0.00% |
24-05-31 | 5.255 | 0.00% |
24-05-30 | 5.255 | +1.35% |
Real-time BOERSE MUENCHEN, June 05, 2024 at 04:14 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.08% | 572B | |
+17.85% | 310B | |
+15.45% | 253B | |
+19.26% | 205B | |
+20.43% | 182B | |
+25.50% | 169B | |
+7.39% | 163B | |
+9.66% | 152B | |
-10.57% | 135B |
- Stock Market
- Equities
- A5G Stock
- A5G Stock